Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus
about
New viruses for cancer therapy: meeting clinical needsRetargeting Strategies for Oncolytic Herpes Simplex VirusesOverview of current immunotherapeutic strategies for gliomaOncolytic virotherapy using herpes simplex virus: how far have we come?Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyTrial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyBiological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.Gene therapy for the nervous system: challenges and new strategies.Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVPediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Designing Herpes Viruses as Oncolytics.Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyEpidermal growth factor receptor targeting and challenges in glioblastoma.Strategies in gene therapy for glioblastoma.11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity.Herpes simplex viral vectors: late bloomers with big potential.Oncolytic viruses: a new class of immunotherapy drugs.A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.Viral vectors for therapy of neurologic diseases.Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.Oncolytic virotherapy: the questions and the promise.Retargeting of herpes simplex virus (HSV) vectors.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes.Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic VirusesHerpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
P2860
Q24567699-7A3916EC-6E79-4AFF-9AC5-8AE38F2FDCE2Q26765439-D4A5109F-2AD8-4662-B18E-C0ECE5A0DE62Q26776345-DF09DC25-9563-4E67-9A35-71130C144F0EQ26862461-F6FE030F-02FD-4066-A0AE-9C69CDC6D555Q26998111-082FF772-297B-49A4-8F91-AA0B025C1091Q27021951-2308995F-E0A5-4AA4-9FB0-86BA2A00D80AQ28072347-BDEA8A07-C9BB-4165-8B3A-CBA77D2F8E87Q35153125-9781B96D-55AA-4082-9AEB-B3F4612BF6F5Q35340196-248BFE54-6B4D-4710-B852-A8A5EC7CAA3AQ35591421-B7DFDDDF-BA95-4104-9253-58125B37C6E9Q36109704-63EB0DA7-D161-4D0D-950D-530C720D0657Q36142487-D7C37891-111A-49BC-B227-36EDB6EA6C71Q36266545-B833196F-A0FE-4BC2-8DF1-D0AC215E6581Q36644898-EC1049A1-BC30-42BE-B570-6D4794428088Q36977684-161AC33D-2AAC-465C-AF77-7CB0B59EA989Q37420576-F5E58DDD-58C7-4062-9D8D-E72408E65962Q37667771-E3492ECC-0B5A-4278-8F15-6EF29B7FB3E2Q38185694-AE933BA2-C8DC-4520-91A5-438165BC27EFQ38577450-FB251375-E781-4718-862B-5EDA75DA8CFCQ38714321-B28AC3EE-359F-4F28-B8BC-140EF5A0B0C7Q38735164-B61C249A-4C4E-45B7-A3EC-8B7CFA44CE58Q38746238-7FFE6B80-B924-4DBF-AD6E-B767636DD0F0Q38791776-CBD85DDA-65EE-43DE-BA90-DE02CAFEBFC4Q38924527-CCD9DACB-F23D-4A50-8B08-3B3BE66E5A80Q38950892-382D96A6-05D8-4049-9A9E-DBDA624EDEB6Q40089704-FA9C1C3C-13B9-4B61-9965-15671E58200BQ40124870-AE62A3D6-BB76-4E0A-AC84-118F5938649BQ40310537-C2E4FE4B-08D6-4869-9670-D086E6186CEFQ42684428-27FA100A-F196-4861-9215-E7E254C65382Q56378150-C4BAF29F-DD22-496B-9587-70273898585EQ58779571-580A99E8-AD33-48CC-B89D-23E10005B5A6
P2860
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effective treatment of an orth ...... oncolytic herpes simplex virus
@ast
Effective treatment of an orth ...... oncolytic herpes simplex virus
@en
type
label
Effective treatment of an orth ...... oncolytic herpes simplex virus
@ast
Effective treatment of an orth ...... oncolytic herpes simplex virus
@en
prefLabel
Effective treatment of an orth ...... oncolytic herpes simplex virus
@ast
Effective treatment of an orth ...... oncolytic herpes simplex virus
@en
P2093
P2860
P50
P356
P1433
P1476
Effective treatment of an orth ...... oncolytic herpes simplex virus
@en
P2093
Amy Haseley
Balveen Kaur
Chang-Sook Hong
E Antonio Chiocca
Heechung Kwon
Hiroaki Uchida
Hiroshi Nakashima
Izumi Kumagai
Janet Chan
Ji Young Yoo
P2860
P304
P356
10.1038/MT.2012.211
P577
2012-10-16T00:00:00Z